A Roadmap for Accelerating Therapies for Parkinson's Disease
The discovery of a gene pathway that contributes to Parkinson's risk has opened up a promising new avenue for developing therapies. Delivering a therapy that slows or prevents Parkinson's progression will require intentional and sustained collaboration across stakeholders.